Cases & Deals

BioTheryX establishes patent portfolio for anti-hematological malignancy therapies

Clients BioTheryX, Inc.

Jones Day assists BioTheryX, Inc. in the development of a global patent portfolio related to small molecule drugs for the treatment of hematological malignancies.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.